The 6th International Lung Cancer Summit
The 6th International Lung Cancer Summit is a hybrid conference that will be held at Lausanne, Switzerland or online on the 4th October, 2024 from 10AM CET.
The ILCS24 will offer insights into the latest breakthroughs and developments in lung cancer treatment featuring leading world experts to discuss the latest advances in thoracic oncology.
This conference will use digital platforms to foster meaningful engagement and networking opportunities for attendees from medical offices, universities, and institutes, allowing them to connect with esteemed medical oncologists and industry professionals at the forefront of lung cancer treatment and research. The conference will feature distinguished speakers from the USA, Spain, UK, Italy, Netherlands, France, Austria, and Switzerland.
The The 6th International Lung Cancer Summit will be hosted by Solange Peters and Alfredo Addeo.
The following list of Doctors/Experts in the field of lung cancer will be presenting at the conference:
- Anne Schultheis (Germany)
Advancements in lung cancer diagnostics: current guidelines and emerging tests.
- Anne-Marie Dingemans (Netherlands)
Novel therapeutic options in targeting EGFR and ALK beyond osimertinib and alectinib.
- Roberto Ferrara (Italy)
Rare but actionable: how to target RET, METex14, and NTRK.
- Biagio Ricciuti (USA)
Decoding actionable alterations: insights from KRAS, HER2, and c-MET.
- Jarushka Naidoo (Ireland)
The emerging role of ADCs in lung cancer: navigating timing and applications for optimal use.
- Nuria Maria Novoa (Spain)
Surgical dilemmas in NSCLC: defining resectability for optimal patient outcomes in the IO era.
- Delvys Rodriguez Abreu (Spain)
Tailoring IO in Respectable NSCLC: Personalized Approaches for Improved Outcomes.
- Giannis Mountzios (Greece) – We must seize every opportunity to cease IO and Sandip Patel (USA) – We must maximize IO benefits through prolonged therapy.
“Debate: Balancing Efficacy, Toxicity, and Patient-Centered Care for IO Duration in NSCLC”
- Stephen Liu (USA)
Reshaping our approaches in SCLC: Latest therapeutic options and future strategies.
To connect with fellow professionals, and to explore the latest in lung cancer treatment, Register now and be part of the conversation!
For more information regarding such events, please visit oncodaily.com.